Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
p38 MAP Kinase inhibitors as modulators of pro-inflammatory cytokine-expression for treatment of inflammation-related diseases like rheumatoid arthritis, inflammatory bowel disease, psoriasis, or acute coronary syndrome. More
1,2,4-benzothiadiazine derivatives useful for the treatment of endocrinological system diseases such as hyperinsulinaemia and diabetes. More
A novel drug target and peptide(s) designed to inhibit protein synthesis by specifically preventing formation of the 43S preinitiation complex More
Submolecular Markers that Leverages the Earliest Diagnostic Test of Acute Myocardial Infarction More
A new method for screening for enantiomeric excess which is colorimetric, rapid and sensitive. More
New substituted phenyl compounds useful for the treatment of respiratory disorders e.g. extrinsic or intrinsic or atopic asthma, chronic bronchitis, bronchiectasis and emphysema - multifunctional ?-agonist compounds comprising a reactive oxygen... More
24 hours sustained release capsules More
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More
Whole-body Magnetic Resonance Angiography (MRA) software/system enhancement techniques that provide rapid, high resolution, 3D, imaging capabilities. More
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Angina
- Angina pectoris
- Angina, chronic stable
- Angina, unstable
- Arrhythmia
- Atrial fibrillation
- Cardiac arrythmia
- Cardiomyopathy
- Congestive heart failure
- Coronary artery disease
- Coronary heart disease
- Heart failure
- Ischaemic heart disease
- Myocardial infarction
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us